FDA Grants Octapharma 7-Year Market Exclusivity for Octagam 10%
Rituximab for Children with Lupus Nephritis
EU Approves Tofacitinib Citrate for 2 Pediatric Conditions
FDA Requires New Boxed Warnings on JAK Inhibitors, Places Restrictions on Use
ACR Guidance on Tocilizumab Allocation During Shortage
20 Years of RA Data: First-Line Biologic & Targeted Synthetic DMARD Trends
2-Year Extension Study Supports Voclosporin to Treat Patients with Lupus Nephritis
COVID-19 Vaccine Efficacy & Safety Discussed at Town Hall
Infections, Low IgG Seen in Kids Receiving Rituximab for Rheumatic Disease
- 1
- 2
- 3
- …
- 115
- Next Page »